These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32162875)

  • 1. D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody.
    Bao SH; Frempong ST; Ruan JL
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
    Shi T; Gu ZD; Diao QZ
    Medicine (Baltimore); 2021 Jun; 100(25):e26264. PubMed ID: 34160390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
    Bao SH; Sheng SL; Liao H; Zhou Q; Frempong ST; Tu WY
    Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 29024233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
    Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Liu X; Qiu Y; Yu ED; Xiang S; Meng R; Niu KF; Zhu H
    Am J Reprod Immunol; 2020 Apr; 83(4):e13219. PubMed ID: 31872490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic state of patients with unexplained recurrent spontaneous abortion.
    Lu X; Liu Z; Zhang X; Kang X; Shen W; Zhao A
    Int J Gynaecol Obstet; 2015 Nov; 131(2):161-5. PubMed ID: 26296564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
    Yan X; Wang D; Yan P; Li H
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 12. Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
    Hoxha A; Favaro M; Calligaro A; Del Ross T; Ruffatti AT; Infantolino C; Tonello M; Mattia E; Ruffatti A
    Thromb Haemost; 2020 Jan; 120(1):36-43. PubMed ID: 31634958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
    Song Y; Wang HY; Qiao J; Liu P; Chi HB
    Chin Med J (Engl); 2017 Feb; 130(3):267-272. PubMed ID: 28139508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
    Radin M; Cecchi I; Schreiber K; Rubini E; Roccatello D; Cuadrado MJ; Sciascia S
    Semin Arthritis Rheum; 2020 Jun; 50(3):553-556. PubMed ID: 32089355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?
    Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S
    J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.